Drug Shortage Report for MYLAN-ACYCLOVIR
Report ID | 244619 |
Drug Identification Number | 02242463 |
Brand name | MYLAN-ACYCLOVIR |
Common or Proper name | ACYCLOVIR |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | ACYCLOVIR |
Strength(s) | 400MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100BT |
ATC code | J05AB |
ATC description | DIRECT ACTING ANTIVIRALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2024-12-20 |
Actual start date | 2024-12-20 |
Estimated end date | 2025-01-15 |
Actual end date | 2025-01-14 |
Shortage status | Resolved |
Updated date | 2025-01-21 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v13 | 2025-01-21 | French | Compare |
v12 | 2025-01-21 | English | Compare |
v11 | 2025-01-15 | French | Compare |
v10 | 2025-01-15 | English | Compare |
v9 | 2025-01-07 | French | Compare |
v8 | 2025-01-07 | English | Compare |
v7 | 2024-12-21 | English | Compare |
v6 | 2024-12-16 | French | Compare |
v5 | 2024-12-16 | English | Compare |
v4 | 2024-12-12 | French | Compare |
v3 | 2024-12-12 | English | Compare |
v2 | 2024-12-03 | French | Compare |
v1 | 2024-12-03 | English | Compare |
Showing 1 to 13 of 13